A double blind randomised controlled trial examining the effect of intravenous zoledronic acid on pleural fluid production, breathlessness and quality of life in patients with a malignant pleural effusion.
Phase of Trial: Phase IV
Latest Information Update: 26 Sep 2015
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Lung cancer
- Focus Pharmacodynamics
- 30 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 20 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 20 Jun 2013 Accrual to date is 100% according to United Kingdom Clinical Research Network record.